TOVX logo

Theriva Biologics, Inc.

TOVX
Healthcare|Biotechnology|US
$0.17
-0.00 (-1.13%)
DCF Value
$1.08
Cash / Share
$0.25
Next Earnings Report
Nov 17, 2026
EPS est. -$0.06
Financing Filings (last 12 months)
1
Shelf registrations / offering prospectuses — latest Dec 3, 2025 (424B5). Possible dilution.

Upcoming Data Readouts (2)

Aug 2027
Est. completion
P1P2Pancreas Cancer, Metastatic
A Study of More Frequent Dosing of VCN-01 Combined With Standard Chemotherapy in Patients With Newly Diagnosed Metastatic Pancreatic Cancer
NCT07701486n=6
Sep 2029
Est. completion
P1P2Acute Graft-Versus-Host Reaction Following Bone Marrow Transplant
SYN-004 Safety and Tolerability in Allo-HCT Subjects
NCT04692181n=36

Recent Press Releases

Theriva™ Biologics Announces Sale of SYN-004 (ribaxamase) and Related Antibiotic-Degrading Enzyme Portfolio to Biossil Labs Inc.
Nov 2, 2026 · GlobeNewsWire
Theriva™ Biologics Announces Publication of the Results from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer Published in Nature Medicine
Sep 30, 2026 · GlobeNewsWire
Theriva™ Biologics Reports Second Quarter 2026 Operational Highlights and Financial Results
Aug 11, 2026 · GlobeNewsWire

SEC Filings (85)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 2, 20268-KMaterial eventDocumentIndex
Oct 20, 2026DEF 14AProxy / shareholder voteDocumentIndex
Oct 9, 2026PRE 14AProxy / shareholder voteDocumentIndex
Aug 24, 2026S-8Employee stock planDocumentIndex
Aug 11, 202610-QQuarterly reportDocumentIndex
Aug 11, 20268-KMaterial eventDocumentIndex
Aug 6, 20268-KMaterial eventDocumentIndex
Aug 4, 20268-KMaterial eventDocumentIndex
Jul 7, 20268-KMaterial eventDocumentIndex
Jun 29, 2026DEF 14AProxy / shareholder voteDocumentIndex
Jun 29, 2026ARSAnnual report to holdersDocumentIndex
Jun 18, 2026PRE 14AProxy / shareholder voteDocumentIndex
Jun 11, 20268-KMaterial eventDocumentIndex
Jun 5, 20268-KMaterial eventDocumentIndex
May 5, 202610-QQuarterly reportDocumentIndex
May 5, 20268-KMaterial eventDocumentIndex
Apr 30, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 20, 2026PRE 14AProxy / shareholder voteDocumentIndex
Apr 17, 20268-KMaterial eventDocumentIndex
Apr 9, 20268-KMaterial eventDocumentIndex
Mar 23, 20268-KMaterial eventDocumentIndex
Mar 16, 2026DEF 14AProxy / shareholder voteDocumentIndex
Mar 12, 202610-KAnnual reportDocumentIndex
Mar 12, 20268-KMaterial eventDocumentIndex
Mar 4, 2026PRE 14AProxy / shareholder voteDocumentIndex
Feb 18, 20268-KMaterial eventDocumentIndex
Feb 12, 20268-KMaterial eventDocumentIndex
Jan 12, 20268-KMaterial eventDocumentIndex
Jan 5, 2026DEF 14AProxy / shareholder voteDocumentIndex
Dec 29, 20258-KMaterial eventDocumentIndex
Dec 23, 2025PRE 14AProxy / shareholder voteDocumentIndex
Dec 15, 20258-KMaterial eventDocumentIndex
Dec 3, 2025424B5Offering prospectusDocumentIndex
Dec 2, 2025EFFECTDocumentIndex
Nov 12, 2025DEFA14AProxy / shareholder voteDocumentIndex
Nov 12, 202510-QQuarterly reportDocumentIndex
Nov 12, 20258-KMaterial eventDocumentIndex
Nov 10, 2025SC 13GPassive 5%+ stakeDocumentIndex
Nov 10, 2025DEF 14AProxy / shareholder voteDocumentIndex
Nov 7, 2025S-3Shelf registrationDocumentIndex